Healthcare & Life Sciences

Steptoe attorneys serve all the needs of our healthcare and life science clients. Our attorneys understand the issues facing our healthcare and life sciences clients because they have experience with major representations ranging from incorporating a physician’s practices to defending large medical care corporations and pharmaceutical benefit managers (PBMs) in class action suits to prosecuting, enforcing, and defending pharmaceutical and medical device patents.

Our broad practice is the product of a collaboration of different legal disciplines uniting to provide guidance to this complex and ever-evolving industry both in the United States and Europe.

We help foster, build, and protect healthcare and life sciences companies through our extensive background in regulatory, intellectual property, litigation, products liabilities, unfair competition, trade secret, antitrust, corporate, merger and acquisition, joint venture, tax, ERISA and employment, and immigration matters.

Our team includes a doctor of veterinary medicine; Ph.Ds in chemistry, biochemistry, biomedical sciences and mechanical engineering; and a former Deputy Director for Science Policy and Technology Transfer at the National Institutes of Health.

The firm's experience in healthcare includes matters relating to the development, licensing, and protection of new medical devices and pharmaceuticals, affiliations between healthcare providers, laboratories, and other corporate reorganizations and restructurings, health plan regulation, ERISA issues, HIPPA, PBMs, CHAMPUS contracting, and ADA litigation.

We also counsel and defend healthcare clients in connection with fraud and abuse investigations and charges including alleged antikickback violations and billing fraud.

News

• Steptoe Adds Legal and Government Relations Talent

Events

• Craig Simpson Speaks at IBC Life Sciences 13th Annual BPD Conference

Speaking Engagements

• Regulation of Nanotechnology in Food

Publications

• REACH in practice - challenges for the life sciences sector
  2007
• EU Analyst: Environment & Life Sciences: A Detailed Description of REACH
  February 2007
• Collaboration in Life Sciences Field: Competition Concerns
  IBC Life Sciences' 13th Annual Biocidal Products Directive Conference
  September 27, 2006
• Let's Talk Dirty: How Government Regulators Have Helped and Hindered Redevelopments of Contaminated Property
  December 14, 2004